Chunxiao He

No. 568, Zhongxing North Road
Shaoxing, 312000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone".

Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone".

Journal: International journal of chronic obstructive pulmonary disease

Published: February 23, 2026

Corrigendum to "Nintedanib improves bleomycin-induced pulmonary fibrosis by inhibiting the Clec7a/SPP1 pathway in interstitial macrophages" [Cellular Signalling, 2025 April, Volume 128, 111635].

Corrigendum to "Nintedanib improves bleomycin-induced pulmonary fibrosis by inhibiting the Clec7a/SPP1 pathway in interstitial macrophages" [Cellular Signalling, 2025 April, Volume 128, 111635].

Journal: Cellular signalling

Published: June 10, 2025

Nintedanib improves bleomycin-induced pulmonary fibrosis by inhibiting the Clec7a/SPP1 pathway in interstitial macrophages.

Nintedanib improves bleomycin-induced pulmonary fibrosis by inhibiting the Clec7a/SPP1 pathway in interstitial macrophages.

Journal: Cellular signalling

Published: November 06, 2024

Salidroside alleviates the progression of idiopathic pulmonary fibrosis by regulating ferroptosis.

Salidroside alleviates the progression of idiopathic pulmonary fibrosis by regulating ferroptosis.

Journal: Cytotechnology

Published: August 04, 2024

ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis.

ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis.

Journal: Open life sciences

Published: June 04, 2023

Causal associations between gut microbiota, metabolites and asthma: a two-sample Mendelian randomization study.

Causal associations between gut microbiota, metabolites and asthma: a two-sample Mendelian randomization study.

Journal: BMC pulmonary medicine

Published: March 20, 2023

Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.

Support Vector Machine for Lung Adenocarcinoma Staging Through Variant Pathways.

Journal: G3 (Bethesda, Md.)

Published: May 24, 2020

Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer

Joint serum tumor markers serve as survival predictive model of erlotinib in the treatment of recurrent non-small cell lung cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: May 24, 2014

Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.

Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.

Journal: Chinese medical journal

Published: January 21, 2014

Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified

Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: March 22, 2013

Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma.

Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma.

Journal: Thoracic cancer

Published: March 11, 2013

Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma.

Pretreatment neutrophil-to-lymphocyte ratio as predictor of survival for patients with metastatic nasopharyngeal carcinoma.

Journal: Head & neck

Published: February 28, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026